Genomic Newborn Screening Expands to Detect Hundreds of Rare Genetic Disorders
Genomic newborn screening is undergoing a significant expansion, with pilot studies now sequencing hundreds of genes or even entire genomes from dried blood spots, the same samples used for conventional screening. This advanced approach aims to identify thousands, potentially millions, of children worldwide with rare genetic diseases. Current conventional newborn screening in the U.S. tests for 66 conditions, primarily metabolic disorders, with 98% of the nearly 3.6 million infants born annually undergoing this screening. Genomic screening, however, can detect over 700 disorders. Studies like GUARDIAN and BabyScreen+ have shown promising early results, identifying treatable conditions that would be missed by standard screening. For instance, the GUARDIAN study found that 2.7% of 15,000 newborns had confirmed genetic disorders, with most not identified by current methods, leading to life-saving interventions in some cases. The BabyScreen+ study, which screened 1,000 newborns, reported confirmed findings in ...